-
Featured
Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults
Researchers at Massachusetts General Hospital recently published the results of their analysis of arrhythmias in the UK Biobank, a national cohort of over 500k community-based individuals recruited to assess risk factors for disorders affecting people from middle-age onward.
-
Featured
Largest genetic study establishes hereditary links to atrial fibrillation
A study led by Mass General cardiologist Patrick T. Ellinor, MD, PhD, identified 97 genetic loci that are significantly associated with atrial fibrillation.
-
Featured
Improved Identification of Patients at Risk for Atrial Fibrillation
Steve Lubitz, MD, MPH, discusses his team’s work focusing on understanding the mechanisms of atrial fibrillation through human genetics, and understanding how best to identify patients at risk for the arrhythmia.
-
Accelerometer Data Confirms: Increased Physical Activity Is Associated with Reduced Risk of Afib, Stroke
Using wrist-worn accelerometer data from the UK Biobank, Shaan Khurshid, MD, MPH, and Steven A. Lubitz, MD, MPH, of the Cardiovascular Research Center, and colleagues confirmed guideline-recommended levels of physical activity are associated with substantially lower risks of incident atrial fibrillation and stroke.
-
Infection of the Heart Commonly Seen at Autopsy of Patients Who Died of COVID-19
In the most detailed study to date, Mayara Bearse, MD, and James R. Stone, MD, PhD, of the Department of Pathology, and colleagues, cardiac infection by SARS-CoV-2 was evident in 73% of autopsies of patients who died of COVID-19 and was linked to differences in clinical features and treatment.
-
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
Patrick T. Ellinor, MD, PhD, Steven A. Lubitz, MD, MPH, Thor M. Sundt, MD, and colleagues determined that after cardiac surgery, non–vitamin K antagonist oral anticoagulants are a safe alternative to warfarin for patients with nonvalvular atrial fibrillation who have acceptable bleeding risk.
Arrhythmia Contributors
-
Conor D. Barrett, MBBCh, BAO
Clinical Director, Cardiac Arrhythmia Service
Recent Article
Treating Athletes with Arrhythmias: A Partnership Approach
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Type 2 Myocardial Infarction Is Prevalent in U.S., Has a Distinct Clinical Profile
-
Patrick T. Ellinor, MD, PhD
Director, Cardiac Arrhythmia Service
Recent Article
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
-
Steven A. Lubitz, MD, MPH
Cardiac Electrophysiologist
Recent Article
Accelerometer Data Confirms: Increased Physical Activity Is Associated with Reduced Risk of Afib, Stroke
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
